Gedea Biotech has received 1 MSEK for clinical study for CE mark of new product
Smile Company Gedea Biotech has received 1 MSEK in Vinnova funding in Swelife and MedTech4Health's joint announcement "Project for better health". The money will finance the first clinical trial in patients with vaginal fungal infection. Read more
